Electric-vehicle (EV) battery technology company QuantumScape (NYSE: QS) gave investors a reason to cheer with its third-quarter report last night, and its shares are surging as a result. The stock popped nearly 36% in early morning trading. As of 11:38 a.m. ET, it was still up by 21.6%. The company announced it has achieved an important milestone in its work to develop commercially viable solid-state batteries for EV makers. It has shipped samples planned for its first commercial product to automakers and other original equipment manufacturers (OEMs) for testing. That was one of QuantumScape’s major goals for 2024. QuantumScape has…
Author: user
Ford Motor Company has achieved a remarkable sales performance during the first three quarters of the year, despite a decline in its best selling nameplate, the F-Series. Despite facing challenges in its core market, Ford has managed to outperform its competitors, posting a 2.7% increase in sales compared to the same period last year. The Ford F-Series, America’s most popular full size pickup truck, remains a significant contributor to the company’s success. However, the premium Lincoln division has also played a crucial role in driving growth, with a substantial 25.4% increase in sales. Ford’s Resilient Sales Growth Driven by Lincoln’s…
The Plymouth Barracuda, born on April Fool’s Day 1964, was a pioneer in the burgeoning pony car market. However, its early success was overshadowed by the Ford Mustang, which quickly became the iconic face of the genre. Despite facing stiff competition from rivals like the Camaro, Firebird, Javelin, and eventually its own Dodge sibling, the Challenger, the Barracuda persisted for two generations. In 1970, the Barracuda underwent a significant transformation, adopting the new E-body platform shared with the Dodge Challenger. The 1970 Plymouth Hemi Cuda Convertible: A Rare Muscle Car Masterpiece (mecum) This move marked a turning point for the…
Corporate earnings are not meeting expectations thus far. Roughly 160 S & P 500 companies have posted third-quarter results thus far, with their bottom lines growing an average of just 2.6%, per FactSet. The blended growth rate, which includes the reports already out and estimates for those on the docket, points to overall S & P 500 earnings growing at 3.4% from the year-earlier period. Both of those are below the anticipated 4.2% earnings expansion heading into the reporting period. That number was revised down from an expected 7.8% clip from June . Some of the sluggishness can be attributed…
The Mazda BT-50, a mid-size pickup truck, has been receiving more attention in Australia than in North America. While MNAO appears uninterested in offering the BT-50 with updates like the CX-90’s engine or plug in powertrain, the Australian market has seen significant improvements to the model in recent years. The 2024 model year introduced subtle enhancements and a starting price of $24k, making it a more attractive option for Australian buyers. However, those considering purchasing the BT-50 in Australia might want to wait for the 2025 model year, which is expected to feature substantial design changes, safety upgrades, added functionality,…
The investment landscape is shifting, with many individual investors looking to diversify their portfolios with assets outside traditional stocks and bonds. In less than five years, the global alternative investments market is expected to reach $24.5 trillion, compared to approximately $16.3 trillion at the end of 2023, according to the Future of Alternatives 2028 report by research firm Preqin. As fund managers expand their product offerings and key changes are implemented, alternatives have become more accessible than ever to individual investors. What are alternative investments? Alternative investments refer to multiple types of nontraditional investments that expose investors to private opportunities…
Rizoma, a renowned Italian accessory supplier, has collaborated with Ducati to create a limited edition Scrambler motorcycle. Renowned for their high quality custom parts, Rizoma’s influence is often seen in the motorcycle world, but this time they’ve taken a more direct role. The Ducati Scrambler 10° Anniversario Rizoma Edition is a tribute to their decade long partnership and features a host of Rizoma components. While mechanically similar to the standard Scrambler, this limited edition boasts unique design elements that set it apart. The exposed engine parts not only enhance the bike’s aesthetic appeal but also showcase the intricate engineering behind…
The contemporary operating landscape is increasingly defined by both resilience and vulnerability. These two themes were central to WEX Inc.’s third-quarter 2024 earnings call on Thursday (Oct. 24). The company, which provides payment processing, fleet management and benefits solutions, told investors it continues to navigate a complex macroeconomic environment that affected its performance in key segments. However, executives remain committed to WEX’s long-term growth strategy, driven by investments in artificial intelligence (AI) and product development. “We continued to deliver growth and strong profitability in the third quarter, driven by healthy sales, high customer retention, and expanding margins. That said, our…
Audi Sport’s RS 6 Avant GT special edition, a limited run tribute to an IMSA racing legend, is poised to make a substantial impact on the North American market. Despite facing competition from a larger model lineup at BMW M, Audi Sport is confident in the RS 6 Avant GT’s ability to fascinate enthusiasts with its exceptional performance and exclusivity. This high performance station wagon boasts a powerful 621 horsepower engine, delivering exhilarating acceleration and thrilling driving dynamics. Coupled with its striking design, the RS 6 Avant GT offers a unique and visually appealing package. Audi Sport’s Limited Edition RS…
Investing.com — Shares of Intellia Therapeutics (NASDAQ:NTLA), Inc. took a nosedive today, dropping around 20% after the company announced results from the Phase 2 study of its investigational gene-editing therapy, NTLA-2002, for hereditary angioedema (HAE). Despite the data indicating a reduction in HAE attacks, analysts expressed caution about the therapy’s competitive position and inherent risks. Intellia’s press release highlighted that the Phase 2 trial, which involved 27 participants, demonstrated a 75% to 81% reduction in monthly attack rates for patients receiving NTLA-2002. They said eight out of eleven patients in the higher 50 mg dose group reported a complete response,…